The mean coverage depths, along with their corresponding standard deviations, for the different groups were as follows: NEG: 24.84 ± 37.94; NAT: 26.37 ± 39.94; and CRC: 31.53 ± 44.91. This evidence concerns the gene BRD2 and colorectal carcinoma.